Influence of R-type (Cav2.3) and T-type (Cav3.1-3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis

Neuroscience

Volumn 120, Issue 3, 2003, Pages 757-764

  Bergquist, F ^a   Nissbrandt, H ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Mibefradil; Nickel(II); Rat; SNX 482; Striatum; Substantia nigra

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL R TYPE; CALCIUM CHANNEL T TYPE; DOPAMINE; MIBEFRADIL; SNX 482; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DIALYSATE LEVEL; DOPAMINE BLOOD LEVEL; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; EXTRACELLULAR CALCIUM; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0041765715     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00385-3     Document Type: Article

References (54)

1. 2+ channels are coupled to the rapid component of secretion in mouse adrenal slice chromaffin cells. J Neurosci. 20:2000;8323-8330.
2. Bergquist F., Jonason J., Pileblad E., Nissbrandt H. Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra a microdialysis study in rat . J Neurochem. 70:1998;1532-1540.
3. Bergquist F., Niazi H.S., Nissbrandt H. Evidence for different exocytosis pathways in dendritic and terminal dopamine release in vivo. Brain Res. 950:2002;245-253.
4. 2+ channel antagonist mibefradil (Ro 40-5967). Mol Pharmacol. 48:1995;540-549.
5. Björklund A., Lindvall O. Dopamine in dendrites of substantia nigra neurons suggestions for a role in dendritic terminals . Brain Res. 83:1975;531-537.
6. Bourinet E., Stotz S.C., Spaetgens R.L., Dayanithi G., Lemos J., Nargeot J., Zamponi G.W. Interaction of SNX482 with domains III and IV inhibits activation gating of alpha(1E) (Ca(V)2.3) calcium channels. Biophys J. 81:2001;79-88.
7. 2+ dependence and time course of somatodendritic dopamine release substantia nigra versus striatum . J Neurosci. 21:2001;7841-7847.
8. Chen B.T., Rice M.E. Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area. J Neurochem. 81:2002;158-169.
9. Chéramy A., Leviel V., Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature. 289:1981;537-542.
10. Cobb W.S., Abercrombie E.D. Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol. J Neurosci. 22:2002;1407-1413.
11. Cuello A.C., Iversen L.L. Interactions of dopamine with other neurotransmitters in the rat substantia nigra: a possible functional role of dendritic dopamine. 1978;Raven Press, New York.
12. Dajas F., Silveira R., Costa G., Castello M.E., Jerusalinsky D., Medina J., Levesque D., Greenfield S. Differential cholinergic and noncholinergic actions of acetylcholinesterase in the substantia-nigra revealed by fasciculin-induced inhibition. Brain Res. 616:1993;1-5.
13. El Ayadi A., Afailal I., Errami M. Effects of voltage-sensitive calcium channel blockers on extracellular dopamine levels in rat striatum. Metab Brain Dis. 16:2001;121-131.
14. Elverfors A., Jonason J., Jonason G., Leonsson G., Nissbrandt H. Determination of release of endogenous dopamine from superfused substantia nigra slices. J Neurosci Methods. 45:1992;209-215.
15. Elverfors A., Jonason J., Jonason G., Nissbrandt H. Effects of drugs interfering with sodium channels and calcium channels. Synapse. 26:1997;359-369.
16. Elverfors A., Pileblad E., Lagerkvist S., Bergquist F., Jonason J., Nissbrandt H. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra. J Neurochem. 69:1997;1684-1692.
17. Falkenburger B.H., Barstow K.L., Mintz I.M. Dendrodendritic inhibition through reversal of dopamine transport. Science. 293:2001;2465-2470.
18. Glowinski J. In vivo release of transmitters in the cat basal ganglia. Fed Proc. 40:1981;135-141.
19. (+) channels in adrenal cells. Mol Pharmacol. 56:1999;1192-1197.
20. Haubrich C., Frielingsdorf V., Herzig S., Schroder H., Schwarting R., Sturm V., Voges J. N-type calcium channel blockers tools for modulation of cerebral functional units? Brain Res. 855:2000;225-234.
21. 2+ channels in rat CNS neurones. Neuroreport. 6:1995;1621-1624.
22. Kalivas P.W., Duffy P. A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J Neurochem. 56:1991;961-967.
23. Kato T., Otsu Y., Furune Y., Yamamoto T. Different effects of L-, N- and T-type calcium channel blockers on striatal dopamine release measured by microdialysis in freely moving rats. Neurochem Int. 21:1992;99-107.
24. Lee J.H., Gomora J.C., Cribbs L.L., Perez-Reyes E. Nickel block of three cloned T-type calcium channels low concentrations selectively block alpha1H . Biophys J. 77:1999;3034-3042.
25. Li W.Y., Thaler C., Brehm P. Calcium channels in Xenopus spinal neurons differ in somas and presynaptic terminals. J Neurophysiol. 86:2001;269-279.
26. Llinas R., Greenfield S.A., Jahnsen H. Electrophysiology of pars compacta cells in the in vitro substantia nigra a possible mechanism for dendritic release . Brain Res. 294:1984;127-132.
27. 2+ channels in apical dendrites of rat CA1 pyramidal neurons. J Physiol. 487:1995;67-90.
28. Magnelli V., Baldelli P., Carbone E. Antagonists-resistant calcium currents in rat embryo motoneurons. Eur J Neurosci. 10:1998;1810-1825.
29. Martin R.L., Lee J.H., Cribbs L.L., Perez-Reyes E., Hanck D.A. Mibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther. 295:2000;302-308.
30. Nair M.S., Subbalakshmi G. Multiple equilibria involved in some nickel(II) mixed ligand complex systems containing catecholic and dipeptide ligands. J Indian Chem Soc. 77:2000;26-28.
31. 2+ conductances in guinea-pig substantia nigra pars compacta neurones. J Physiol (Lond). 466:1993;727-747.
32. Nedergaard S., Greenfield S.A. Sub-populations of pars compacta neurons in the substantia nigra the significance of qualitatively and quantitatively distinct conductances . Neuroscience. 48:1992;423-437.
33. Newcomb R., Szoke B., Palma A., Wang G., Chen X.H., Hopkins W., Cong R., Miller J., Urge L., Tarczy-Hornoch K., Loo J.A., Dooley D.J., Nadasdi L., Tsien R.W., Lemos J., Miljanich G. Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas. Biochemistry (Mosc). 37:1998;15353-15362.
34. Nieoullon A., Cheramy A., Glowinski J. Release of dopamine in vivo from cat substantia nigra. Nature. 266:1977;375-377.
35. Norregaard L., Frederiksen D., Nielsen E.O., Gether U. Delineation of an endogenous zinc-binding site in the human dopamine transporter. EMBO J. 17:1998;4266-4273.
36. 2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis. Br J Pharmacol. 123:1998;805-814.
37. Rall W., Shepherd G.M., Reese T.S., Brightman M.W. Dendrodendritic synaptic pathway for inhibition in the olfactory bulb. Exp Neurol. 14:1966;44-56.
38. Randall A.D., Tsien R.W. Contrasting biophysical and pharmacological properties of T-type and R-type calcium channels. Neuropharmacology. 36:1997;879-893.
39. Rice M.E., Richards C.D., Nedergaard S., Hounsgaard J., Nicholson C., Greenfield S.A. Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro. Exp Brain Res. 100:1994;395-406.
40. Robertson G.S., Damsma G., Fibiger H.C. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J Neurosci. 11:1991;2209-2216.
41. Sabatini B.L., Svoboda K. Analysis of calcium channels in single spines using optical fluctuation analysis. Nature. 408:2000;589-593.
42. Santiago M., Westerink B.H. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. J Neurochem. 57:1991;738-747.
43. 2+ channel alpha 1 subunit. Receptors Channels. 2:1994;255-270.
44. Smith P.A. The use of low concentrations of divalent cations to demonstrate a role for N-methyl-D-aspartate receptors in synaptic transmission in amphibian spinal cord. Br J Pharmacol. 77:1982;363-373.
45. Soong T.W., Stea A., Hodson C.D., Dubel S.J., Vincent S.R., Snutch T.P. Structure and functional expression of a member of the low voltage-activated calcium channel family. Science. 260:1993;1133-1136.
46. Stockand J., Sultan A., Molony D., DuBose T. Jr, Sansom S. Interactions of cadmium and nickel with K channels of vascular smooth muscle. Toxicol Appl Pharmacol. 121:1993;30-35.
47. Timmermann D.B., Westenbroek R.E., Schousboe A., Catterall W.A. Distribution of high-voltage-activated calcium channels in cultured gamma-aminobutyric acidergic neurons from mouse cerebral cortex. J Neurosci Res. 67:2002;48-61.
48. Tottene A., Moretti A., Pietrobon D. Functional diversity of P-type and R-type calcium channels in rat cerebellar neurons. J Neurosci. 16:1996;6353-6363.
49. Tottene A., Volsen S., Pietrobon D. alpha(1E) subunits form the pore of three cerebellar R-type calcium channels with different pharmacological and permeation properties. J Neurosci. 20:2000;171-178.
50. Westerink B.H., de Boer P., Santiago M., De Vries J.B. Do nerve terminals and cell bodies of nigrostriatal dopaminergic neurons of the rat contain similar receptors? Neurosci Lett. 167:1994;109-112.
51. Viana F., VanDenBosch L., Missiaen L., Vandenberghe W., Droogmans G., Nilius B., Robberecht W. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones. Cell Calcium. 22:1997;299-311.
52. 2+ channel modulation by syntaxin 1A. Proc Natl Acad Sci USA. 99:2002;3968-3973.
53. Wolfart J., Roeper J. Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons. J Neurosci. 22:2002;3404-3413.
54. 2+ currents evoke transmitter release at a rat central synapse. Proc Natl Acad Sci USA. 95:1998;4720-4725.